Webinar Recording: Edgewise Therapeutics – Update on Sevasemten Program in Becker and Duchenne
Edgewise Therapeutics recently joined PPMD for a community webinar for an update on the company’s sevasemten program in Duchenne and Becker. The Edgewise team reviewed new Open-label Extension MESA data in Becker, as well as…Learn More